The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

William C. Zamboni

Department of Pharmaceutical Sciences

School of Pharmacy

University of Pittsburgh




Name/email consistency: high



  • Department of Pharmaceutical Sciences, School of Pharmacy, University of Pittsburgh, Pittsburgh, USA. 2002 - 2008
  • Program of Molecular Therapeutics and Drug Discovery, University of Pittsburgh Cancer Institute, PA 15213, USA. 2000 - 2006


  1. Tumor, tissue, and plasma pharmacokinetic studies and antitumor response studies of docetaxel in combination with 9-nitrocamptothecin in mice bearing SKOV-3 human ovarian xenografts. Zamboni, W.C., Strychor, S., Joseph, E., Parise, R.A., Egorin, M.J., Eiseman, J.L. Cancer Chemother. Pharmacol. (2008) [Pubmed]
  2. Plasma and tissue disposition of non-liposomal DB-67 and liposomal DB-67 in C.B-17 SCID mice. Zamboni, W.C., Jung, L.L., Strychor, S., Joseph, E., Zamboni, B.A., Fetterman, S.A., Sidone, B.J., Burke, T.G., Curran, D.P., Eiseman, J.L. Invest. New. Drugs (2008) [Pubmed]
  3. Plasma, tumor, and tissue disposition of STEALTH liposomal CKD-602 (S-CKD602) and nonliposomal CKD-602 in mice bearing A375 human melanoma xenografts. Zamboni, W.C., Strychor, S., Joseph, E., Walsh, D.R., Zamboni, B.A., Parise, R.A., Tonda, M.E., Yu, N.Y., Engbers, C., Eiseman, J.L. Clin. Cancer Res. (2007) [Pubmed]
  4. Disposition of 9-nitrocamptothecin and its 9-aminocamptothecin metabolite in relation to ABC transporter genotypes. Zamboni, W.C., Ramanathan, R.K., McLeod, H.L., Mani, S., Potter, D.M., Strychor, S., Maruca, L.J., King, C.R., Jung, L.L., Parise, R.A., Egorin, M.J., Davis, T.A., Marsh, S. Invest. New. Drugs (2006) [Pubmed]
  5. Relationship between plasma exposure of 9-nitrocamptothecin and its 9-aminocamptothecin metabolite and antitumor response in mice bearing human colon carcinoma xenografts. Zamboni, W.C., Jung, L.L., Egorin, M.J., Hamburger, D.R., Joseph, E., Jin, R., Strychor, S., Ramanathan, R.K., Eiseman, J.L. Clin. Cancer Res. (2005) [Pubmed]
  6. Systemic and tumor disposition of platinum after administration of cisplatin or STEALTH liposomal-cisplatin formulations (SPI-077 and SPI-077 B103) in a preclinical tumor model of melanoma. Zamboni, W.C., Gervais, A.C., Egorin, M.J., Schellens, J.H., Zuhowski, E.G., Pluim, D., Joseph, E., Hamburger, D.R., Working, P.K., Colbern, G., Tonda, M.E., Potter, D.M., Eiseman, J.L. Cancer Chemother. Pharmacol. (2004) [Pubmed]
  7. Phase I and pharmacologic study of intermittently administered 9-nitrocamptothecin in patients with advanced solid tumors. Zamboni, W.C., Jung, L.L., Egorin, M.J., Potter, D.M., Friedland, D.M., Belani, C.P., Agarwala, S.S., Wong, M.M., Fakih, M., Trump, D.L., Jin, R., Strychor, S., Vozniak, M., Troetschel, M., Ramanathan, R.K. Clin. Cancer Res. (2004) [Pubmed]
  8. Pharmacokinetics of pegfilgrastim. Zamboni, W.C. Pharmacotherapy (2003) [Pubmed]
  9. An overview of the pharmacokinetic disposition of darbepoetin alfa. Zamboni, W.C., Stewart, C.E. Pharmacotherapy (2002) [Pubmed]
  10. The effect of increasing topotecan infusion from 30 minutes to 4 hours on the duration of exposure in cerebrospinal fluid. Zamboni, W.C., Lüftner, D.I., Egorin, M.J., Schweigert, M., Sezer, O., Richter, T., Natale, J.J., Possinger, K. Ann. Oncol. (2001) [Pubmed]
  11. Pharmacodynamic model of topotecan-induced time course of neutropenia. Zamboni, W.C., D'Argenio, D.Z., Stewart, C.F., MacVittie, T., Delauter, B.J., Farese, A.M., Potter, D.M., Kubat, N.M., Tubergen, D., Egorin, M.J. Clin. Cancer Res. (2001) [Pubmed]
  12. Pharmacokinetic and pharmacodynamic study of the combination of docetaxel and topotecan in patients with solid tumors. Zamboni, W.C., Egorin, M.J., Van Echo, D.A., Day, R.S., Meisenberg, B.R., Brooks, S.E., Doyle, L.A., Nemieboka, N.N., Dobson, J.M., Tait, N.S., Tkaczuk, K.H. J. Clin. Oncol. (2000) [Pubmed]
WikiGenes - Universities